Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Prevention of cancers of the breast, endometrium and ovary

Oncogene volume 23, pages 6379–6391 (2004)Cite this article

Abstract

A central epidemiological feature of cancers of the breast, endometrium and ovary is the sharp slowing down in their rate of increase with age around the time of menopause. The incidence of these tumors by the age of 70 years would be between fourfold and eightfold increased if the rapid increase with age seen in young women continued into old age. These phenomena can be explained by the different effects of ovarian hormones on cell division rates in the relevant tissues. Models of these effects provide a plausible explanation of most of the known epidemiology of each of the cancers, including the increase in breast cancer risk from menopausal estrogen–progestin therapy. Some recent epidemiological findings in endometrial and ovarian cancer suggest new avenues for possible chemoprevention of these cancers.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Albrektsen G, Heuch I, Tretli S and Kvale G . (1995). Int. J. Cancer, 61, 485–490.

  • Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S and Women's Health Initiative Steering Committee. (2004). JAMA, 291, 1701–1712.

  • Anderson JT, Ferguson DJP and Raab GM . (1982). Br. J. Cancer, 46, 376–382.

  • Bernstein L, Hanisch R, Sullivan-Halley J and Ross RK . (1995). Cancer Epidemiol. Biomarkers Prev., 4, 437–440.

  • Bernstein L, Yuan JM, Ross RK, Pike MC, Hanisch R, Lobo R, Stanczyk F, Gao YT and Henderson BE . (1990). Cancer Causes Control, 1, 51–58.

  • Blankenstein MA, van de Ven J, Maitimu-Smeele I, Donker GH, de Jong PC, Daroszewski J, Szymczak J, Milewicz A and Thijssen JH . (1999). J. Steroid Biochem. Mol. Biol., 69, 293–297.

  • Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL and Yaffe MJ . (1995). J. Natl. Cancer Inst., 87, 670–675.

  • Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ and Hopper JL . (2002). N. Engl. J. Med., 347, 886–894.

  • Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lannom L and Hoover RN . (1992). Am. J. Obstet. Gynecol., 167, 1317–1325.

  • Cairns J . (2002). Proc. Natl. Acad. Sci. USA, 99, 10567–10570.

  • Cancer and Steroid Hormone Study (1987a). JAMA, 257, 796–800.

  • Cancer and Steroid Hormone Study (1987b). N. Engl. J. Med., 316, 650–655.

  • Casagrande JT, Pike MC, Ross RK, Louie EW, Roy S and Henderson BE . (1979). Lancet, 2, 170–173.

  • Cauley JA, Norton L, Lippman ME, Eckert S, Krueger KA, Purdie DW, Farrerons J, Karasik A, Mellstrom D, Ng KW, Stepan JJ, Powles TJ, Morrow M, Costa A, Silfen SL, Walls EL, Schmitt H, Muchmore DB, Jordan VC and Ste-Marie LG . (2001). Breast Cancer Res. Treat., 65, 125–134.

  • Cerin A, Heldaas K and Moeller B . (1996). N. Engl. J. Med., 334, 668–669.

  • Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A and WHI Investigators. (2003). JAMA, 289, 3243–3253.

  • Colditz GA and Rosner B . (2000). Am. J. Epidemiol., 152, 950–964.

  • Collaborative Group on Hormonal Factors in Breast Cancer (1997). Lancet, 350, 1047–1059.

  • Cramer DW, Hutchison GB, Welch WR, Scully RE and Ryan KJ . (1983). J. Natl. Cancer Inst., 71, 711–716.

  • Cutler SJ and Young JL . (1975). Natl. Cancer Inst. Monogr., 41.

  • Dao TL . (1981). Hormones and Breast Cancer. Pike MC, Siiteri PK and Welsch CW (eds). Cold Spring Harbor Laboratory: Cold Spring Harbor, pp. 281–298.

    Google Scholar 

  • Doll R . (1971). J. R. Stat. Soc. Ser. A., 134, 133–165.

  • Dubeau L . (1999). Gynecol. Oncol., 72, 437–442.

  • El-Bastawissi AY, White E, Mandelson MT and Taplin S . (2001). Ann. Epidemiol., 11, 257–263.

  • Engeland A, Tretli S and Bjorge T . (2003). J. Natl. Cancer Inst., 95, 1244–1248.

  • Ettinger B, Selby J, Citron JT, Vangessel A, Ettinger VM and Hendrickson MR . (1994). Obstet. Gynecol., 83, 693–700.

  • Fairfield KM, Willett WC, Rosner BA, Manson JE, Speizer FE and Hankinson SE . (2002). Obstet. Gynecol., 100, 288–296.

  • Farrow DC, Weiss NS, Lyon JL and Daling JR . (1989). Am. J. Epidemiol., 129, 1300–1304.

  • Fathalla MF . (1972). Obstet. Gynecol. Surv., 27, 751–768.

  • Flowers CE, Wilborn WH and Hyde BM . (1983). Obstet. Gynecol., 61, 135–143.

  • Fujimoto I, Hanai A and Oshima A . (1979). Natl. Cancer Inst. Monogr., 53, 5–15.

  • Gapstur SM, Lopez P, Colangelo LA, Wolfman J, Van Horn L and Hendrick RE . (2003). Cancer Epidemiol. Biomarkers Prev., 12, 1074–1080.

  • Goldin BR, Adlercreutz H, Gorbach SL, Woods MN, Dwyer JT, Conlon T, Bohn E and Gershoff SN . (1986). Am. J. Clin. Nutr., 44, 945–953.

  • Gram IT, Ursin G, Spicer DV and Pike MC . (2001). Cancer Epidemiol. Biomarkers Prev., 10, 1117–1120.

  • Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC and Ursin G . (2003). J. Natl. Cancer Inst., 95, 30–37.

  • Henderson BE and Pike MC . (1981). Hormones and Breast Cancer. Pike MC, Sitteri PK and Welsch CW (eds). Cold Spring Harbor Laboratory: Cold Spring Harbor, pp. 115–130.

    Google Scholar 

  • Henderson BE, Casagrande JT, Pike MC, Mack T, Rosario I and Duke A . (1983). Br. J. Cancer, 47, 749–756.

  • Henderson BE, Pike MC and Casagrande JT . (1981). Lancet, 2, 363.

  • Henderson BE, Ross RK, Pike MC and Casagrande JT . (1982). Cancer Res., 42, 3232–3239.

  • Hoel DG, Wakabayashi T and Pike MC . (1983). Am. J. Epidemiol., 118, 78–89.

  • Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH, Seow A, Lee HP and Yu MC . (2002). Cancer Epidemiol. Biomarkers Prev., 11, 608–613.

  • Janerich DT . (1979). Lancet, 1, 1240–1241.

  • Kelsey JL and Bernstein L . (1996). Annu. Rev. Public Health, 17, 47–67.

  • Key TJ and Pike MC . (1988). Br. J. Cancer, 57, 205–212.

  • Key TJ, Chen J, Wang DY, Pike MC and Boreham J . (1990). Br. J. Cancer, 62, 631–636.

  • King RJ and Whitehead MI . (1984). Medical Management of Endometriosis . Raynaud JP, Ojasoo T and Martini L (eds). Raven Press: New York, pp. 67–77.

    Google Scholar 

  • Kuper H, Cramer DW and Titus-Ernstoff L . (2002). Cancer Causes Control, 13, 455–463.

  • Kvale G, Heuch I and Ursin G . (1988). Cancer Res., 48, 6217–6221.

  • Lacey Jr JV, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A and Schairer C . (2002). JAMA, 288, 334–341.

  • Lambe M, Wuu J, Weiderpass E and Hsieh CC . (1999). Cancer Causes Control, 10, 43–49.

  • Lane G, Siddle NC, Ryder TA, Pryse-Davies J, King RJB and Whitehead MI . (1986). Fertil. Steril., 45, 345–352.

  • Lee NC, Wingo PA and Peterson HB . (1986). Aging, reproduction, and the climacteric Mastroiani Jr L and Paulsen CA (eds). Plenum Press: New York.

    Google Scholar 

  • Lippman SM and Brown PH . (1999). J. Natl. Cancer Inst., 91, 1809–1819.

  • Lubin F, Chetrit A, Freedman LS, Alfandry E, Fishler Y, Nitzan H, Zultan A and Modan B . (2003). Am. J. Epidemiol., 157, 113–120.

  • Lukanova A, Toniolo P, Lundin E, Micheli A, Akhmedkhanov A, Biessy C, Lenner P, Krogh V, Berrino F, Hallmans G, Riboli E and Kaaks R . (2002). Int. J. Cancer, 99, 603–608.

  • Magnusson C, Baron JA, Correia N, Bergstrom R, Adami H-O and Persson I . (1999). Int. J. Cancer, 81, 339–344.

  • McPherson CP, Sellers TA, Potter JD, Bostick RM and Folsom AR . (1996). Am J Epidemiol., 143, 1195–1202.

  • Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, Mosgaard BJ, Purdie DM, Risch HA, Vergona R and Wu AH . (2002). Am. J. Epidemiol., 155, 217–224.

  • Ness RB, Grisso JA, Klapper J, Schlesselman JJ, Silberzweig S, Vergona R, Morgan M, Wheeler JE and SHARE Study Group. (2000). Am. J. Epidemiol., 152, 233–241.

  • Newhouse ML, Pearson RM, Fullerton JM, Boesen EAM and Shannon HS . (1977). Br. J. Prev. Soc. Med., 31, 148–153.

  • Office of Population Censuses and Surveys (1978). Decennial Supplement, Occupation and Mortality, 1970–72 (DS No. 1.). HMSO: London.

  • Paterson MEL, Wade-Evans T, Sturdee DW, Thom MH and Studd JW . (1980). BMJ, 22, 822–824.

  • Pearce CL, Wu AH, Wan P and Pike MC . (2004) In preparation.

  • Peto R . (1977). Origins of Human Cancer . Hiatt HH, Watson JD and Winsten JA (eds). Cold Spring Harbor Laboratory: Cold Spring Harbor, 1403–1428.

    Google Scholar 

  • Pettersson B, Adami HO, Bergstrom R and Johansson EDB . (1986). Acta Obstet. Gynecol. Scand., 65, 247–255.

  • Piek JM, van Diest PJ, Zweemer RP, Jansen JW, Poort-Keesom RJ, Menko FH, Gille JJ, Jongsma AP, Pals G, Kenemans P and Verheijen RH . (2001). J. Pathol., 195, 451–456.

  • Pike MC . (1987). J. Chron. Dis., 40, 59S–69S.

  • Pike MC, Kolonel LN, Henderson BE, Wilkens LR, Hankin JH, Feigelson HS, Wan P, Stram DO and Nomura AMY . (2002). Cancer Epidemiol. Biomarkers Prev., 11, 795–800.

  • Pike MC, Krailo MD, Henderson BE, Casagrande JT and Hoel DG . (1983). Nature, 303, 767–770.

  • Pike MC, Pearce CL, Peters R, Cozen W, Wan P and Wu AH . (2004). Fertil. Steril., 82, 186–195.

  • Pike MC, Peters RK, Cozen W, Probst-Hensch NM, Felix JC, Wan PC and Mack TM . (1997). J. Natl. Cancer Inst., 89, 1110–1116.

  • Pike MC, Ross RK, Lobo RA, Key TJA, Potts M and Henderson BE . (1989). Br. J. Cancer, 60, 142–148.

  • Pike MC, Spicer DV, Dahmoush L and Press MF . (1993). Epidemiol. Rev., 15, 17–35.

  • Purdie DM, Bain CJ, Siskind V, Russell P, Hacker NF, Ward BG, Quinn MA and Green AC . (1999). Br. J. Cancer, 81, 559–563.

  • Purdie DM, Bain CJ, Webb PM, Whiteman DC, Pirozzo S and Green AC . (2001). Cancer Causes Control, 12, 855–863.

  • Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM and Persson IR . (2002a). Am. J. Epidemiol., 156, 363–373.

  • Riman T, Dickman PW, Nilsson S, Correia N, Nordliner H, Magnusson CM, Weiderpass E and Persson IR . (2002b). J. Natl. Cancer. Inst., 94, 497–504.

  • Risch HA, Marrett LD and Howe GR . (1994). Am. J. Epidemiol., 140, 585–597.

  • Risch HA . (1996). Gynecol. Oncol., 63, 254–257.

  • Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ and Thun MJ . (2002a). Cancer Epidemiol. Biomarkers Prev., 11, 822–928.

  • Rodriguez C, Patel AV, Calle EE, Jacob EJ and Thun MJ . (2001). JAMA, 285, 1460–1465.

  • Rodriguez GC, Nagarsheth NP, Lee KL, Bentley RC, Walmer DK, Cline M, Whitaker RS, Isner P, Berchuck A, Dodge RK and Hughes CL . (2002b). J. Natl. Cancer Inst., 94, 50–60.

  • Rodriguez GC, Walmer DK, Cline M, Krigman H, Lessey BA, Whitaker RS, Dodge R and Hughes CL . (1998). J. Soc. Gynecol. Invest., 5, 271–276.

  • Rosner B, Colditz GA and Willett WC . (1994). Am. J. Epidemiol., 139, 819–835.

  • Ross RK, Paganini-Hill A, Wan PC and Pike MC . (2000). J. Natl. Cancer Inst., 92, 328–332.

  • Royar J, Becher H and Chang-Claude J . (2002). Int. J. Cancer, 95, 370–374.

  • Russo IH, Koszalka M and Russo J . (1991). Br. J. Cancer, 54, 481–484.

  • Russo J and Russo IH . (1994). Cancer Epidemiol. Biomarkers Prev., 3, 353–364.

  • Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L and Hoover R . (2000). JAMA, 284, 691–694.

  • Schildkraut JM, Calingaert B, Marchbanks PA, Moorman PG and Rodriguez GC . (2002). J. Natl. Cancer Inst., 94, 32–38.

  • Schildkraut JM, Cooper GS, Halabi S, Calingaert B, Hartge P and Whittemore AS . (2001). Obstet. Gynecol., 98, 85–90.

  • Schouten LJ, Goldbohm RA and van den Brandt PA . (2003). Am. J. Epidemiol., 157, 424–433.

  • Shimizu H, Ross RK, Bernstein L, Pike MC and Henderson BE . (1990). Br. J. Cancer, 62, 451–453.

  • Siiteri PK and MacDonald PC . (1973). Handbook of Physiology Section 7, Part I, Vol. 2 American Physiological Society: Washington, DC, pp. 615–629.

    Google Scholar 

  • Siiteri PK, Hammond GL and Nisker JA . (1981). Hormones and Breast Cancer . Pike MC, Siiteri PK and Welsch CW (eds). Cold Spring Harbor Laboratory: Cold Spring Harbor, pp. 87–106.

    Google Scholar 

  • Simeons ATW . (1954). Lancet, 2, 946–947.

  • Sit ASY, Modugno F, Weissfeld JL, Berga SL and Ness RB . (2002). Gynecol. Oncol., 86, 118–123.

  • Spicer D, Shoupe D and Pike MC . (1991). Contraception, 44, 289–310.

  • Spicer DV, Pike MC, Pike A, Rude R, Shoupe D and Richardson J . (1993). Contraception, 47, 427–444.

  • Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A and Pike MC . (1994). J. Natl. Cancer Inst., 86, 431–436.

  • Titus-Ernstoff L, Perez K, Cramer DW, Harlow BL, Baron JA and Greenberg ER . (2001). Br. J. Cancer, 84, 714–721.

  • Tornberg SA and Carstensen JM . (1994). Br. J. Cancer., 69, 358–361.

  • Tung KH, Goodman MT, Wu AH, McDuffie K, Wilkens LR, Kolonel LN, Nomura AM, Terada KY, Carney ME and Sobin LH . (2003). Am. J. Epidemiol., 158, 629–638.

  • Ursin G, Astrahan MA, Salane M, Parisky YR, Pearce JG, Daniels JR, Pike MC and Spicer DV . (1998). Cancer Epidemiol. Biomarkers Prev., 7, 43–47.

  • Waterhouse J, Muir C, Correa P and Powell J (eds). (1976). Cancer Incidence in Five Continents . IARC Scientific Publication No. 1 IARC: Lyon, France.

    Google Scholar 

  • Weiss NS, Lyon JL, Krishnamurthy S, Dietert SE, Liff JM and Daling JR . (1982). J. Natl. Cancer Inst., 68, 95–98.

  • Welsch CW . (1981). Hormones and Breast Cancer. Pike MC, Siiteri PK and Welsch CW (eds). Cold Spring Harbor Laboratory: Cold Spring Harbor, pp. 299–315.

    Google Scholar 

  • Whiteman DC, Siskind V, Purdie DM and Green AC . (2003). Cancer Epidemiol. Biomarkers Prev., 12, 42–46.

  • Whittemore AS, Harris R, Itnyre J and the Collaborative Ovarian Cancer Group. (1992). Am. J. Epidemiol., 136, 1184–1203.

  • Williams DB, Voigt BJ, Yao SF, Schoenfeld MJ and Judd HL . (1994). Obstet. Gynecol., 84, 787–793.

  • Zhou H, Luo M, Schonthal AH, Pike MC, Stallcup MR, Zheng W and Dubeau L . (2002). Cancer Biol., 1, 300–306.

Download references

Author information

Authors and Affiliations

  1. USC/Norris Cancer Center, Los Angeles, CA, USA

    Malcolm C Pike, Celeste Leigh Pearce & Anna H Wu

Authors
  1. Malcolm C Pike
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Celeste Leigh Pearce
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna H Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Malcolm C Pike.

Additional information

Declaration of conflict of interest

Dr. Pike is associated with Balance Pharmaceuticals, Inc.; a company set up to develop the GNRHA contraceptive discussed above.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pike, M., Pearce, C. & Wu, A. Prevention of cancers of the breast, endometrium and ovary. Oncogene 23, 6379–6391 (2004). https://doi.org/10.1038/sj.onc.1207899

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207899

Keywords

This article is cited by

Search

Advanced search

Quick links